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T he effect of isotretinoin on the chemotaxis ofhuman mon-
ocytes was studied in an in vitro sys tem using a Nucleopore 
chamber. The chemoattractant used w as zymosan-acti-
vated serum . Inhibition of monocyte chemotaxis was 
achieved with isotretinoin in concentrations of 1 X 10 - 3 
T he in trodu ction of o ral retin oids has been a major advance in the treatment o f many skin dis. eases. Cystic acne res ponds well to oral retinoid therapy and pro-longed remissions have been observed [1]. . T he mechanism of action of isotretino in is complex 
and multi fac to rial (2-1 0], but its anti-inflammatory properties 
may be a major facto r in its effi cacy. Inflammatory lesions are 
noted both clinica lly and microscopicall y in acne. These lesions 
are what cause the grea test scarrin g, bo th physical and psycho-
logical. In ea rly lesions the predominant infiltrative cell is the 
neutrophil , but monocytes are present as well in later lesions [11] . 
T he present stud y was undertaken to assess the effects of iso-
tretinoin on tn onocyte chemotaxis since monocytes are an integral 
part of the chronic inflammatory response. 
MATERIALS AN D METH ODS 
Isotretinoin (R04-3780) was provided by H offman-La Roche In c. 
Nutley, N ew Jersey. 
Leukocyte Donors Peripheral blood monocy tes were obtained 
by venipuncture from healthy m ale and fe male donors who were 
not takin g any medications (their ages ranged from 20-40). 
Isolation of Monocytes Isolation of monocytes was based on 
the method of Pert oft et al [1 2). Peripheral venous blood (1 0 ml) 
was drawn into heparinized polypropylene tubes. T his was mixed 
with an equal volume of Hanks' balanced salt solution (HE SS) 
and layered onto lsolymph (Gall ard-Schlesinger Chemical Mfg. 
Corp. Ca rle Place, N ew York). After a 15-min centri fugation at 
1000 rpm, the mononuclear cell layer was harves ted and washed 
with equal volumes of HESS. The pellet was then mi xed with 
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Abbreviatio ns: 
BSA: bovine se rum albumin 
FCS: fetal calf se rum 
H BSS: H anks' balanced salt solu tion 
HPF: high-power fie lds 
PMN: po ly mo rphonuclea r leukocyte 
Z AS: zym osan-activa ted serum 
M and 5 X 10 - 4 M . It is felt that the improvement seen in 
patients with inflammatory skin diseases such as cystic acne 
and acne conglobata who are treated w ith iso tretinoin m ay 
in part be a result of this anti-inflammatory action . j Jm;esf 
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1 ml o f 0.01 M EDT A/ fetal calf serum (FC S). After a 10-min 
incubation at 37°C, 6 ml of HE SS was added and the combination 
was layered onto 3 ml of Perco ll (Pharm acia Fine C hemica ls AB, 
U ppsala, Sweden) working solution fv/ v (9 ml Percoll :1 ml 
1. 5 M N aCl) w ith 0.15 M N aCI]. After a 30-min centrifugation 
at 1000 rpm , the monocytes were harves ted and washed w ith 
HESS w ithout Phenol Red, M g+ + and Ca + + . 
Cell Suspension Cells were suspended in either 2%, 1%, or 
0.5% bovine serum albumin (BSA) in GIBCO RPM!-1640 (RPM!). 
Cell prepara tions were at a concentration of5 X 10r• cells/ml and 
contained 80% monocytes w ith a 20% conta mination w ith lym-
phocytes. Cells were then combined w ith equ al volumes of ei ther 
2 X 10- J M or 1 X 10- 3 M ofi sotretin oin prepared in 2%, 1%, 
or 0. 5% BSA in RPMI w ith 2.5% DMSO. T he cell suspensions 
were then incubated for 60 min at 37°C w ith mild agita tion in 
complete da rkness. 
Chemotaxis: Chambers and Filter Nucleopore acry lic cham-
bers were used with a 5-JLm pore filter (Millipore Corp. , Bedfo rd, 
Massachusetts). The upper chamber contained 0.5 ml o f cell sus-
pension and the lower 0.2 ml o f the chemoattractant. 
Chemotactic Factor Z ymosa n-activated serum (ZA S) : 1 ml 
of pooled human serum was mi xed w ith 20 m g o f zy mosan and 
incubated for 30 min at 37"C. Nine milliliters of RPMJ/DMSO 
was then add ed to get a fm al concentration of l 0% ZAS. Fresh 
human serum was pooled monthly to assure complem ent activity 
and stored at - 70°C. Iso tretinoin in concentrations o f 1 X 
10 - 3 M and 5 X 10 - 4 M was also used as a chemoattractant . 
Chemotaxis Assay T en percent ZAS (0.2 ml) w as added to 
the lower chamber, the 5-JLm filter was then put in place, and 
0.5 ml o f cell suspension w as added to the upper chamber. Each 
chamber was run in duplica te. After a 90-min incubation at 37"C, 
the fluid was aspirated fro m the upper chamber and the fi lters 
were immediatel y fi xed in absolute alcohol, stained w ith hema-
toxylin , rinsed in distilled wa ter, and dehydrated in graded series 
of ethanol before clearing in xylene. The filters were then mounted 
bottom side up under coverslips with Perm ount. 
Counting T he chemotac tic activity was evaluated by taking 
the average counts in 5 random high-power fields (HPF) of the 
number of monocytes found on the lower fi lter surface. Results 
of chemotaxis activity were expressed in the number o f m ono-
cytes per HPF after subtracting chemokinesis (random migra-
tion). The direct mi gration of untreated cells toward the chem o-
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attractant suspended in RPMJ/DMSO was assessed as a positive 
control. The migration toward RPMI/DMSO alone was assessed 
as a negative control. Percent inhibition was calcu lated by the 
equation: 
% inhibition [ 1 (-t_r_ea_t_e_d_c_e_II_s __ r_at_ld_o,--m_c_el_Is_· ) J x 100 
= - no trea tment random cells 
Viability of cells was tested via trypan blue dye excl usion at the 
conclusion of each experiment and was found to be > 99% for 
each chamber. 
RESULTS 
The mean values for random migration and migration to ZAS 
with untreated cells suspended in 2% , 1%, and 0.5% BSA arc 
listed in Table I. For random migration, no sign ificant changes 
were noted when the 2 concentrations of drug were introduced 
or with different concentrations of BSA. However, when the 
cells were treated with 1 X 10- J M and 5 X 10 - 4 M of iso-
tretinoin, inhibition of migration was noted with those cells sus-
pended in 1% and 0.5% BSA but not 2% BSA (p < 0.01). The 
mean distance for migration with drug concentrations of 1 X 
10- 3 M and 5 X JQ - ·I M are li sted in Table I. lsotretinoi n in con-
centrations of 1 X 10 - 3 M and 5 x JQ - '1 M did not sign ifican tly 
cause monocyte chemotactic ac tivity ( < 5 cells /HPF). Jsotrc-
tinoin tested at concentra tions less than or eq ual to 1 X JQ - 5 M 
did not s how any significant effect on mo nocyte chemotaxis. 
The percent inhibition for migration is depicted in Fig lA. 
The mean number of cells migrating to the average distance 
for random migration and to ZAS w ith untreated cells suspended 
in 2%, 1 °/o, and 0.5% BSA are listed in Table II . No significant 
changes were noted for the different concentrations ofBSA. When 
the cells were incubated w ith 1 X JQ - 3 M and 5 X JQ - 4 M of 
isotretinoin, the mean numbers of cells mig ratin g were seen to 
be inhibited in 1% and 0.5% BSA but not in 2% BSA (p < 0.01). 
The number of cells migrating is listed in Table II. The percent 
inhibi tion of number of cells is depicted in Fig 1 B. 
The day-to-day variation and donor-to-donor va riation were 
fo und to be Jess than 10%. 
DISCUSSION 
The n ew therapeutic era that was ushered in with the introduction 
of oral retinoids has revolutionized the therapy for many sk in 
diseases. Early studies pointed to the ability of isotretinoin to 
change the composition of skin lipids by inhibiting sebaceous 
glands [2-4,8, 9). Skin flora changes have also been reported with 
the density of Propionibacteri11m awes seen decreasing with isotre-
tinoin's usage [4,5 , 10) . Therapy has also been associated with 
inhibi tion of chemotaxis and chemiluminescence of the poly-
morphonuclea r leukocytes (PMN) [6) as well as inhibition of 
lysosom.al enzyme release [7) . 
The N ucleopo re chamber has been used to study leukocy te 
Table L Chemotactic Activity of Monocytes with Different 
Concentrations of lsotretinoin Incubated with the Cells and 
Placed in the Upper C hambers 
2% BSA I% BSA 0.5% BSA 
Medium alone 20.2 :t 4.3 20.4 :t 3.2 23.0 
Medium a lone 84.2 :t 5.8 85.5 :t 5.6 80.0 
+ zymosan 
1 X 10 - 3 M RA 82.4 :t 4.2 31.3 :t 3.4 30.0 
+ zymosan 
5X 10- 4 M RA 86.6 :t 4.8 20.0 :t 2.6 24.0 
+ zymosan 
Va lues arc expressed as means of p.m migrated ± I SD. The cells were suspended 
m different concentra tions of bovine serum albumin (BSA). RA = isotrctinoin. 
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Figure 1. The effect ofisotretinoin on monocyte chemotaxis . Monocytcs 
were suspended in 0.5% (~). 1% (0) . or 2% (0) BSA-RPMI medium 
and treated with isotretinoin (RA) before exposure to zymosan-activated 
se rum. The results arc expressed as percent inhibition :t SO. The number 
of experiments performed is shown in parent/Jest's. A. Percent inhibition 
for migration; B, percent inhibition of number of cell s migrating. 
chemotaxis in the laboratory (1 3-15]. The system has also been 
used to study the effects of drugs on migration of the cells to be 
studied [1 3,15, 16). 
Two monocyte chemoattractant factors present in acne lesions 
have been isolated: PMN lysate released and a so luble filtrate of 
P. awes [17]. 
Once the peripheral monocyte leaves the circulation and enters 
the area of inflammation, it functions in a manner similar to the 
PMN in its microbicidal and cytotoxic activity. The monocyte, 
however, is a more hig hl y developed " killer" once activated. 
Although intimate contact between the macrophage and its target 
cell triggers optimum action, the activated macrophage will re-
lease toxic substances in suffi cient quantities to kill nonadherent 
target cells. These substances , once released, will add to the tissue 
damage already caused by the enzymes released from PMN in 
the same lesion (1 8-20]. 
In vitro, concentrations of l X JQ - 3 M and 5 X 10 - 4 M of 
isotretinoin arc able to inhibit monocyte chemotaxis in a manner 
similar to that observed for PMNs. Although these concentrations 
are higher than those achieved in sera of treated patients, it is 
possible that there is an accum ulation of the drug in the follicle 
and these concentrations arc reached in the target lesion. 
Retinoic acids have been shown to have both intra- and ex-
tranuclear effects. Specific membrane receptors for retinoic acids 
have also been repo rted [21 ,22j. The f.1et that inhibition is not 
seen when the cells are suspended in 2% BSA but is seen with 
1% and 0.5% BSA leads to the possibility that the BSA, in higher 
concentration, is somehow either coating the membrane pre-
venting drug access or competin g with the drug for receptor sites 
on the membrane. The chemotactic response of monocyte prep-
arations made w ithout human serum albumin was shown to be 
depressed [14). The function of the protein may be to increase 
the negative charge on the monocyte membrane or to aid in the 
presentation of chemotactic factor to the cell [23) . 
The inhibition of chemotaxis should help to decrease the in-
fl ammatory lesions in acne patients. This ant i-inflammatory effect 
that isotrctinoin has on the monocyte may in part be responsible 
for the excellent resu lts seen w ith the usc of this drug clinicall y. 
Table II. Number of Cells Migrating to the Average 
Distance with Different Concentrations of Isotretinoin. 
In cubated with the Cells and Placed in the Upper C hambers 
2% BSA 1% BSA 0.5% BSA 
Medium alone 10.4 :t 4.0 14.5 :t 2.1 19. 
Medium alone 27.6 :t 5.2 28.0 :t 1.8 30.0 
+ zymosan 
X 10 - 3 M RA 26.2 :t 5. I 15. 8 :t 5.2 21.0 
+ zymosan 
5 X 10 - 4 M RA 25.4 :t 7.0 14.8 :t 3.8 20.0 
+ zymosan 
Values arc expressed as means of cells migrated/ HPF ± I SD. The cells were 
suspended in different concentrations of bo vine serum albumin (BSA) . RA = is-
Otrctinoin . 
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